Allyson J. Ocean - 22 Feb 2023 Form 3 Insider Report for NovoCure Ltd (NVCR)

Role
Director
Signature
Steven Robbins, as attorney in fact for Allyson J. Ocean
Issuer symbol
NVCR
Transactions as of
22 Feb 2023
Net transactions value
$0
Form type
3
Filing time
03 Mar 2023, 15:09:41 UTC
Next filing
06 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NVCR Stock Options (Right to buy) 22 Feb 2023 Ordinary Shares 13,989 $76.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options will vest in equal parts on the first, second and third anniversary of the grant date.